Press Releases

 
Press Releases
  Date Title View
Nov 20, 2014
Highlights Revenues increased 27% year-over-year to EUR 20.3 million (USD 27.4 million) for the first nine months of 2014 HIFU revenue increased 114% year-over-year during first nine months of 2014 Positive operating income, excluding FDA-related costs, for three and nine months ended September 30, 2014 S...
Nov 6, 2014
LYON, France, Nov. 6, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today received a letter from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on its current PMA application for Ablatherm Integrated Imaging Device. The FDA letter stated that while E...
Nov 4, 2014
LYON, France, Nov. 4, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the third quarter ended September 30, 2014 on Thursday, November 20, 2014, during pre-market hours. Company management will host a conference call on Thursday, ...
Oct 21, 2014
LYON, France, Oct. 21, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale of a Focal One system to Nantes-Atlantis urology clinic, the top-ranked private prostate cancer clinic in France, and the country's only private clinic exclusively dedicated to urology. Nantes-Atla...
Oct 13, 2014
LYON, France, Oct. 13, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that data on clinical outcomes of its Ablatherm-HIFU FDA study (the "Enlight Trial") will be presented at the 4th International Symposium of the Focused Ultrasound Foundation ("FUSF"), being held October 12-14, 201...
Oct 7, 2014
LYON, France, Oct. 7, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first successful treatments performed at Germany's Mannheim University Hospital ("UMM"), using the Company's Focal One® HIFU device. UMM is home to one of the largest urological Centers in Germany, ...
Sep 22, 2014
LYON, France, Sept. 22, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the growing interest in and acceptance of its Ablatherm®-HIFU technology was once again highlighted as a valuable treatment alternative for prostate cancer patients in a presentation at the World Congress of E...
Aug 28, 2014
Highlights Revenues increased 28% year-over-year to EUR 13.4 million for the first six months 104% growth in its HIFU business outside of USA for the first six months Solid financial profile with cash position of $17.5 million Strong backlog of orders in both HIFU and ESWL entering Third Quarter ...
Aug 26, 2014
LYON, France, Aug. 26, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced its participation in the Seventh International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer, which took place in Los Angeles, August 21-23, 2014. The congress is a joint initiative of the Universi...
Aug 11, 2014
LYON, France, Aug. 11, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2014 results announcement, which will take place on August 28, 2014, before the opening of the market. EDAP will hold a conference call on Thursday, August 28, 2014 at...
1
... NextLast
= add release to Briefcase